Brainworks

IBH | March 31, 2021

IBH, a population, and digital health services pioneer, announced the acquisition of Uprise, a digital health platform that delivers highly customized treatment through self-guided modules, live coaching, and in-person counseling. The acquisition of Uprise follows IBH's latest acquisition of HMC HealthWorks in December 2020, which expanded IBH's presence in chronic disease management. This new ac...

HEALTH TECHNOLOGY

nference | September 22, 2022

nference, a science-first software company transforming healthcare by making biomedical data computable announced the launch of its AI-driven nSights platform, which will allow biopharma, medical device companies, and diagnostic firms to access and directly engage with curated, de-identified healthcare data to advance research and discovery. The company also expanded its exclusive 12-year strategic relationship with Mayo Clinic, providing nference partners and customers with access ...

HEALTHCARE ANALYTICS

symplr | February 10, 2022

symplr®, the leader in enterprise healthcare operations including governance, risk management, and compliance ("GRC") SaaS solutions, backed by Clearlake Capital Group, L.P. (together with its affiliates, "Clearlake") and Charlesbank Capital Partners (together with its affiliates, "Charlesbank"), announced today that it has completed its acquisition of Midas Health Analytics Solutions ("Midas") from Conduent Incorporated("Conduent")...

HITInfrastructure | March 26, 2020

A drug discovery platform powered by artificial intelligence (AI) technology has identified 18 potential treatments for COVID-19, according to an annuncement from health IT company Gero. Six of the potential anti-COVID-19 drugs have already been approved, three have been withdrawn, and the other nine have already been tested in clinical trials for other indications. The COVID-19 outbreak and the legal and regulatory status of these drugs have made it possible to start various clinical tria...